An 8-week double-blind randomized placebo-controlled trial in 62 patients with PWS demonstrated an improvement of hyperphagiaevaluated as behavior and severity scores by Dykens Hyperphagia Questionnaireafter Topiramate group versus placebo group, with no effects on BMI [95]
Learning about the long-term rewards, such as better weight control, a lower risk of diabetes, and an improved quality of life, can inspire persistence when obstacles appear
Legal Disclaimer: Statements regarding dietary supplements have not been evaluated by the FDA
PlexusDx compounded GLP-1 therapies deliver affordable access immediately, with semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan and tirzepatide at $289/month, without requiring patents to expire or generics to launch
This means discontinuing Retatrutide after reaching goal weight typically leads to weight regain
Guo et al., 2013b)